🇺🇸 FDA
Patent

US 9873702

Heterocyclic compounds as biogenic amine transport modulators

granted A61PA61P25/00A61P25/04

Quick answer

US patent 9873702 (Heterocyclic compounds as biogenic amine transport modulators) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Jan 18 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Jan 23 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 18 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
4
CPC classes
A61P, A61P25/00, A61P25/04, A61P25/24, A61P25/30